ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $341,000 | -67.8% | 4,059 | -63.5% | 0.01% | -68.0% |
| Q1 2019 | $1,058,000 | -42.9% | 11,130 | -57.4% | 0.02% | -46.8% |
| Q4 2018 | $1,854,000 | -31.3% | 26,143 | -17.9% | 0.05% | -14.5% |
| Q3 2018 | $2,698,000 | -26.4% | 31,826 | +0.0% | 0.06% | -29.5% |
| Q2 2018 | $3,666,000 | +68.1% | 31,817 | +18.1% | 0.08% | +62.5% |
| Q1 2018 | $2,181,000 | +558.9% | 26,951 | +377.8% | 0.05% | +500.0% |
| Q4 2017 | $331,000 | – | 5,641 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| Ativo Capital Management LLC | 14,031 | $1,199,000 | 0.32% |